Please wait while we load the requested 10-K report or click the link below:
USANA Health Sciences Announces Fourth Quarter and Full-Year 2013 Financial Results
- Fourth quarter net sales increased by 10.5% to $186.3 million
- Fourth quarter earnings per share increased by 11.0% to $1.41
- 2013 marks 11th consecutive year of record sales ($718.2 million)
- Earnings per share increased to a record $5.56 for the year
- Initial 2014 net sales and earnings outlook provided
SALT LAKE CITY--(BUSINESS WIRE)--February 4, 2014--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full-year ended December 28, 2013. The Company also provided net sales and earnings guidance for 2014.
For the fourth quarter of 2013, net sales increased by 10.5% to $186.3 million, compared with $168.5 million in the prior-year period. The Company’s Asia Pacific and North America/Europe regions both reported sales and customer growth for the quarter. This growth was driven by the successful adoption of the initiatives launched at the Company’s 2013 International Convention held in August. The initiatives, which are designed to promote long-term sustainable customer growth, provide customers with opportunities for preferred pricing and additional compensation under the Company’s Associate compensation plan. Unfavorable changes in currency exchange rates reduced net sales in the quarter by $2.9 million.
The following information was filed by Usana Health Sciences Inc (USNA) on Tuesday, February 4, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Usana Health Sciences Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Usana Health Sciences Inc.